Koln, Germany
InfanDx AG i.L., founded in 2010, is a promising player in the Health Care industry, specializing in developing innovative diagnostic solutions specifically for neonates. The company’s compelling slogan, "Novel Diagnostic Solutions for Neonates," aptly reflects its commitment to advancing child health through cutting-edge technology.
Headquartered in Cologne, Germany, with operations in Berlin and a subsidiary in Boston, MA, USA, InfanDx AG is strategically positioned in key health care markets. Led by experienced industry veterans, the company focuses on high-value diagnostic solutions in prenatal testing and neonatal care, highlighting its expertise and potential for impact.
Their financial trajectory includes a notable €6.00M Series A investment completed on 01 July 2021, backed by prominent investors such as Life Science Inkubator, Alluti GmbH, and Jochen Tschunke. This recent funding round underscores confidence in their vision and capabilities, positioning InfanDx AG as a viable prospect for continued growth and innovation within the pediatric diagnostics sphere.
